CÚRAM’s soft tissue research addresses conditions like diabetic foot ulcers, hernias, and cancer using advanced regenerative therapies. Key projects include developing cell-scaffold bio-complexes for non-healing diabetic ulcers and using nanoparticle-hydrogel systems to treat gastroenterological conditions and cancer. These innovative approaches accelerate tissue regeneration, target inflammation, and improve treatment efficacy, transforming patient care and outcomes.

Additionally, CÚRAM explores innovative drug delivery systems for more effective, localised cancer therapies, minimising side effects and improving treatment efficacy. CÚRAM’s innovative solutions in soft tissue research are transforming treatment paradigms, with a strong focus on improving patient quality of life and clinical outcomes.